Delivery Order SPE2DB25D3017-SPE2DB26FVGTN
- Not listed
- The Defense Logistics Agency awarded a $17,849.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) with an ultimate completion date of June 24, 2025. This non-set-aside competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, with a completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units. This non-competitive, firm fixed-price delivery order was awarded on April 30, 2025, with an ultimate completion date of May 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $17,863.71 to AmerisourceBergen Drug Corp for OJJAARA 150 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 16, 2025, with an ultimate completion date of August 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors and...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of OJJAARA 150 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $17,863.71, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total ceiling value of $999,999,999.00 through December 2026. The contract contains no set-aside...
- The Defense Logistics Agency (DLA) awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. The contract, which represents a child award under AmerisourceBergen's larger IDC with DLA, is scheduled for completion by August 25, 2025. The award was made on a competitive basis with no set-aside designation, and the pharmaceutical products will be delivered to the company's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for OJJAARA 100 mg tablets in quantities of 30, with a contract ceiling value of $17,912.32. This firm fixed-price delivery order, set to be completed by August 14, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $17,849.85 on September 9, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-set-aside, competitively awarded contract supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp on September 26, 2025, for supply of Ojjaara 200 mg tablets in 30-count units. This firm fixed price contract, with an ultimate completion date of October 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order was competitively awarded with no...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGTNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count unit doses. This firm fixed-price delivery order, issued on October 24, 2025, with completion scheduled for November 17, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company maintains a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX) through December 2026, which functions as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order is consistent with AmerisourceBergen's extensive portfolio of competitively awarded contracts with the Defense Logistics Agency Medical Supply Chain, demonstrating the company's established capability to fulfill federal pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 10/24/25 |